| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 60.31B | 62.22B | 58.76B | 52.82B | 47.93B | 39.79B |
| Gross Profit | 15.41B | 16.34B | 14.36B | 13.20B | 11.70B | 9.04B |
| EBITDA | 2.90B | 3.38B | 1.98B | 2.14B | 1.60B | 544.50M |
| Net Income | 1.17B | 1.52B | 542.01M | 1.01B | 702.50M | -746.54M |
Balance Sheet | ||||||
| Total Assets | 28.26B | 29.51B | 26.64B | 29.13B | 25.04B | 22.95B |
| Cash, Cash Equivalents and Short-Term Investments | 5.91B | 5.34B | 3.74B | 4.27B | 5.52B | 4.56B |
| Total Debt | 11.91B | 10.96B | 10.66B | 13.79B | 11.61B | 12.00B |
| Total Liabilities | 18.76B | 19.08B | 17.61B | 20.38B | 17.33B | 16.71B |
| Stockholders Equity | 9.51B | 10.43B | 9.03B | 8.75B | 7.72B | 6.24B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.60B | 2.92B | -3.21B | 741.61M | -200.70M |
| Operating Cash Flow | 0.00 | 3.16B | 3.80B | 1.69B | 1.70B | 857.09M |
| Investing Cash Flow | 0.00 | -1.83B | -812.91M | -4.87B | -976.59M | -1.10B |
| Financing Cash Flow | 0.00 | 58.97M | -3.42B | 1.94B | 289.86M | 140.47M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥22.58B | -13.86 | ― | 1.87% | 4.26% | 27.55% | |
72 Outperform | ¥32.33B | 12.37 | ― | 1.96% | 0.57% | 7.20% | |
65 Neutral | ¥13.56B | 9.53 | ― | 1.43% | 5.88% | 180.90% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
62 Neutral | ¥34.10B | 4.55 | ― | 0.80% | 12.41% | 129.01% | |
52 Neutral | ¥23.69B | 53.09 | ― | 1.32% | -0.63% | -0.70% | |
46 Neutral | ¥33.74B | 21.75 | ― | 1.65% | -1.17% | -95.57% |